Action Potential Duration

Action Potential Duration (APD) refers to the length of time from the initial rapid depolarization of a cardiac myocyte membrane potential until the membrane potential returns to its resting state during a single cardiac action potential. It represents the temporal window during which the cardiac cell remains electrically active, encompassing the phases of depolarization, plateau, and repolarization. APD is typically measured in milliseconds and is a critical parameter influencing the refractory period of cardiac cells, thereby affecting the heart’s rhythm and susceptibility to arrhythmias.

Electrophysiological Basis of Action Potential Duration

Phases of the Cardiac Action Potential

The cardiac action potential consists of five distinct phases (0 to 4), each contributing to the overall APD:

• Phase 0 (Rapid Depolarization): Triggered by the sudden opening of fast voltage-gated sodium (Na⁺) channels, allowing a rapid influx of Na⁺ ions and causing a quick upstroke in membrane potential.
• Phase 1 (Initial Repolarization): Characterized by transient outward potassium (K⁺) currents causing a brief partial repolarization.
• Phase 2 (Plateau Phase): Marked by a balance between inward L-type calcium (Ca²⁺) currents and outward K⁺ currents, resulting in a sustained depolarized state that prolongs the APD.
• Phase 3 (Repolarization): Dominated by increased K⁺ efflux through various potassium channels, restoring the membrane potential back toward the resting level.
• Phase 4 (Resting Membrane Potential): The cell remains at a stable negative resting potential maintained primarily by inward rectifier K⁺ channels and the Na⁺/K⁺-ATPase pump.

APD spans from the beginning of phase 0 to the completion of phase 3, encompassing the entire active electrical event of the cardiac myocyte.

Ionic Currents Influencing APD

The duration of the action potential is determined by the interplay of multiple ionic currents:

• Inward currents:
  • Fast Na⁺ current (I_Na) initiates depolarization but is brief.
  • L-type Ca²⁺ current (I_Ca,L) sustains the plateau and prolongs APD.
• Outward currents:
  • Transient outward K⁺ current (I_to) contributes to early repolarization.
  • Delayed rectifier K⁺ currents (I_Kr, I_Ks) facilitate repolarization.
  • Inward rectifier K⁺ current (I_K1) stabilizes the resting potential.

The balance between these currents regulates the shape and length of the action potential.

Measurement and Quantification of Action Potential Duration

Methods of Measurement

APD is commonly measured using microelectrode recordings or patch-clamp techniques in isolated cardiac myocytes or tissue preparations. It can also be indirectly assessed in whole hearts or in vivo via electrocardiographic surrogates, such as the QT interval, which reflects the summed APD of ventricular myocardium.

Parameters and Definitions

• APD at 90% repolarization (APD90): Time from depolarization onset until the membrane potential repolarizes to 90% of its amplitude.
• APD at 50% repolarization (APD50): Time to 50% repolarization, often used to assess plateau duration.
• Restitution properties: The relationship between APD and the preceding diastolic interval, indicating how APD adapts with heart rate changes.

Accurate measurement of APD and its changes under different physiological or pathological conditions provides insight into the electrophysiological state of the myocardium.

Physiological and Pathophysiological Significance of Action Potential Duration

Role in Normal Cardiac Function

APD determines the refractory period of cardiac cells, during which they are unexcitable to subsequent stimuli. This refractory period ensures coordinated contraction and prevents premature re-excitation, thereby maintaining proper heart rhythm and efficient pumping function.

Influence on Arrhythmogenesis

Alterations in APD can predispose the myocardium to arrhythmias:

• Prolonged APD: Can lead to early afterdepolarizations (EADs), triggering abnormal electrical activity and conditions such as torsades de pointes.
• Shortened APD: May cause reentrant arrhythmias by reducing refractory periods, enabling premature conduction.

Changes in ion channel function, electrolyte imbalances, ischemia, or pharmacological agents can modify APD, thus influencing arrhythmic risk.

Modulation of Action Potential Duration

Autonomic Nervous System Effects

• Sympathetic stimulation: Increases calcium currents and enhances repolarizing potassium currents, generally shortening APD.
• Parasympathetic stimulation: Through acetylcholine-activated K⁺ currents (I_K,ACh), can shorten APD, especially in atrial myocytes.

Pharmacological Modulation

Many antiarrhythmic drugs target APD by altering ion channel activity:

• Class III agents: Block potassium channels to prolong APD and refractory period.
• Class I agents: Modify sodium channels, indirectly affecting APD.
• Calcium channel blockers: Reduce plateau phase duration, shortening APD.

Such modulation is utilized therapeutically to prevent or terminate arrhythmias by stabilizing electrical activity.

Mathematical Representation of Action Potential Duration

APD can be expressed as the time interval between the onset of phase 0 depolarization and the point of repolarization to a specified percentage of the total amplitude. If Vm(t) represents the membrane potential at time t, and Vm_rest and Vm_peak are the resting and peak potentials respectively, then APD at x% repolarization (APDx) is defined by the time t such that:

Here, t_0 is the time of depolarization onset (phase 0), and t_x is the time when the membrane potential reaches x% repolarization.

Clinical Relevance and Applications

Monitoring and understanding APD are crucial in clinical cardiology:

• Risk stratification: Prolonged QT intervals on ECG indicate APD prolongation, associated with increased risk of sudden cardiac death.
• Drug safety: Assessment of drug-induced APD changes is a standard component of preclinical cardiac safety evaluations.
• Personalized medicine: Genetic mutations affecting ion channels alter APD and predispose individuals to inherited arrhythmia syndromes, guiding tailored therapeutic approaches.

APD thus serves as a fundamental electrophysiological parameter linking cellular mechanisms to clinical outcomes in cardiac health and disease.